And Jim, just recently, a couple days ago, and we're going to need to do a whole episode on it, there was a, I think, a Cleveland Clinic analysis that showed decreased progression of metastatic cancer and, you know, several different kinds of cancers, meaning decreased metastatic disease, which is huge
Some trials have shown that participants lost a higher percentage of body weight with tirzepatide than with a similar treatment over a similar treatment period
Diabetologia 65(12):19251966 Berra C, Manfrini R, Mirani M, Bucciarelli L, Zakaria AS, Piccini S et al (2023) AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus
Semaglutide shows promise as a potential alcohol use disorder medication Intramural scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), and collaborators from The Scripps Research Institute, found that semaglutide reduces alcohol consumption and binge-like drinking in a rodent model of alcohol misuse
Beyond weight loss: the emerging role of incretin-based treatments in cardiometabolic HFpEF
Klinic accepts insurance and manages prior authorization for weight loss medication insurance for treatments like Wegovy and Zepbound